Short interest in Enliven Therapeutics Inc (NASDAQ:ELVN) increased during the last reporting period, rising from 6.51M to 6.91M. This put 36.17% of the company's publicly available shares short.

Short interest for Enliven Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Enliven Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 193.88K shares traded per day, it would take 35.62 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.